特別セッション 2　核医学の礎である放射化学の新展開

[1A05] The efficacy of astatine-211-labeled anti-fibroblast growth factor receptor 4(FGFR4) antibody on dissemination of gastric cancer in immunocompetent mice

*Komei Kuge^1,2, Hiroki Masuda^1,2, Wanying Du¹, Tomohiko Yasuda³, Akira SugiySugiyama⁴, Hiromitsu Haba⁵, Toshifumi Tatsumi⁶, Nobuyoshi Akimitsu⁴, Yoshitaka Kumakura⁷, Hiroshi Yoshida², Yasuyuki Seto¹, Youichiro Wada⁴, Sachiyo Nomura¹ (1. Department of Gastrointestinal Surgery, Graduate School of Medicine, The University of Tokyo, 2. Department of Gastrointestinal and Hepato-Biliary-Pancreatic Surgery, Nippon Medical School, 3. Department of Gastrointestinal Surgery, Nippon Medical School Chiba Hokusoh Hospital, 4. Isotope Science Center, The University of Tokyo, 5. Nishina Center for Accelerator-based Science, RIKEN, 6. Graduate School of Pharmaceutical Sciences, The University of Tokyo, 7. Department of Diagnostic Radiology and Nuclear Medicine, Saitama Medical Center, Saitama Medical University)